Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol

NCT01537692 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: BDP HFA Nasal Aerosol
DRUG: BDP HFA Nasal Aerosol
DRUG: BDP HFA Inhalation Aerosol (QVAR)

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.